Evan D Chinoy1,2,3, Michael P Harris1, Min Ju Kim1,2,4, Wei Wang1,2, Jeanne F Duffy1,2. 1. Division of Sleep and Circadian Disorders, Departments of Medicine and Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA. 2. Division of Sleep Medicine, Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. 3. Warfighter Performance Department, Naval Health Research Center, San Diego, California, USA‡. 4. Department of Neurology, Davos Hospital, Yongin, Korea‡.
Abstract
OBJECTIVES: We tested whether a sleep and circadian-based treatment shown to improve circadian adaptation to night shifts and attenuate negative effects on alertness, performance and sleep in young adults would also be effective in older adults. METHODS: We assessed subjective alertness, sustained attention (psychomotor vigilance task, PVT), sleep duration (actigraphy) and circadian timing (salivary dim-light melatonin onset, DLMO) in 18 older adults (57.2±3.8 years; mean±SD) in a simulated shift work protocol. 4 day shifts were followed by 3 night shifts in the laboratory. Participants slept at home and were randomised to either the treatment group (scheduled evening sleep and enhanced lighting during the latter half of night shifts) or control group (ad-lib sleep and typical lighting during night shifts). RESULTS: Compared with day shifts, alertness and sustained attention declined on the first night shift in both groups, and was worse in the latter half of the night shifts. Alertness and attention improved on nights 2 and 3 for the treatment group but remained lower for the control group. Sleep duration in the treatment group remained similar to baseline (6-7 hours) following night shifts, but was shorter (3-5 hours) following night shifts in the control group. Treatment group circadian timing advanced by 169.3±16.1 min (mean±SEM) but did not shift (-9.7±9.9 min) in the control group. CONCLUSIONS: The combined treatment of scheduled evening sleep and enhanced lighting increased sleep duration and partially aligned circadian phase with sleep and work timing, resulting in improved night shift alertness and performance. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
RCT Entities:
OBJECTIVES: We tested whether a sleep and circadian-based treatment shown to improve circadian adaptation to night shifts and attenuate negative effects on alertness, performance and sleep in young adults would also be effective in older adults. METHODS: We assessed subjective alertness, sustained attention (psychomotor vigilance task, PVT), sleep duration (actigraphy) and circadian timing (salivary dim-light melatonin onset, DLMO) in 18 older adults (57.2±3.8 years; mean±SD) in a simulated shift work protocol. 4 day shifts were followed by 3 night shifts in the laboratory. Participants slept at home and were randomised to either the treatment group (scheduled evening sleep and enhanced lighting during the latter half of night shifts) or control group (ad-lib sleep and typical lighting during night shifts). RESULTS: Compared with day shifts, alertness and sustained attention declined on the first night shift in both groups, and was worse in the latter half of the night shifts. Alertness and attention improved on nights 2 and 3 for the treatment group but remained lower for the control group. Sleep duration in the treatment group remained similar to baseline (6-7 hours) following night shifts, but was shorter (3-5 hours) following night shifts in the control group. Treatment group circadian timing advanced by 169.3±16.1 min (mean±SEM) but did not shift (-9.7±9.9 min) in the control group. CONCLUSIONS: The combined treatment of scheduled evening sleep and enhanced lighting increased sleep duration and partially aligned circadian phase with sleep and work timing, resulting in improved night shift alertness and performance. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Cody Ramin; Elizabeth E Devore; Weike Wang; Jeffrey Pierre-Paul; Lani R Wegrzyn; Eva S Schernhammer Journal: Occup Environ Med Date: 2014-09-26 Impact factor: 4.402
Authors: Melissa A St Hilaire; Heidi M Lammers-van der Holst; Evan D Chinoy; Cheryl M Isherwood; Jeanne F Duffy Journal: Chronobiol Int Date: 2020-09-06 Impact factor: 2.877
Authors: Saranea Ganesan; Michelle Magee; Julia E Stone; Megan D Mulhall; Allison Collins; Mark E Howard; Steven W Lockley; Shantha M W Rajaratnam; Tracey L Sletten Journal: Sci Rep Date: 2019-03-15 Impact factor: 4.379
Authors: Bjørn Bjorvatn; Ståle Pallesen; Siri Waage; Eirunn Thun; Kjersti M Blytt Journal: Scand J Work Environ Health Date: 2020-10-20 Impact factor: 5.024